Skip to main content
Livermore
Livermore
ZHEN

Seelos Therapeutics, Inc.

SEELDelisted Apr 4, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001017491

Seelos Therapeutics, Inc. was delisted on Apr 4, 2025; its insiders filed their last Form 4 on Mar 1, 2024; 23 institutions reported holding it in 13F filings for Q2 2024, worth $129.4K in total; no superinvestor held it.

Holders of 5% or more of SEEL

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Seelos Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of SEEL
HolderLatest formStakeChangeFirst filedLatest filingFiling
Weber Mark13G10.70%46.5K sharesNewNov 25, 20241 filingNov 25, 2024SEC
Jane Street Group, LLC13G6.60%38.3K sharesNewFeb 14, 20251 filingFeb 14, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

7 Schedule 13D and 13G filings on Seelos Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on SEEL
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 14, 20255:12 PM ETLind Global Fund II LPand 3 others13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Feb 14, 20255:09 PM ETJane Street Group, LLCand 1 other13G6.60%38.3K sharesNewDec 31, 2024SEC
Nov 25, 20243:37 PM ETWeber Mark13G10.70%46.5K sharesNewNov 14, 2024SEC
Feb 10, 2022Vanguard Group Inc13G/AOld format–––SEC
Feb 10, 2021Vanguard Group Inc13GOld format–New–SEC
Jan 15, 20214:11 PM ETLigand Pharmaceuticals Inc13G/AOld format–––SEC
Jan 11, 2021Phoenixus AG13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Seelos Therapeutics, Inc. shares.

No Form 144 notices for Seelos Therapeutics, Inc. are on file.